|
WO0016762A2
|
|
Method for reducing nicotine dependency
|
|
AU1408699A
|
|
Cox-2 inhibitors in combination with nmda-blockers for treating pain
|
|
AU1398899A
|
|
Cox-2 inhibitors in combination with centrally acting analgesics
|
|
WO9907413A1
|
|
Substance p inhibitors in combination with nmda-blockers for treating pain
|
|
EP0984781A1
|
|
Analgesic drug composition containing a capsaicinoid and potentiator therefor
|
|
EP0980247A1
|
|
Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
|
|
AU7472798A
|
|
Cox-2 inhibitors in combination with nmda-blockers for treating pain
|
|
US6054451A
|
|
Analgesic composition and method for alleviating pain
|
|
US6007841A
|
|
Analgesic composition and method for treating pain
|
|
WO9807447A1
|
|
Anticonvulsant containing composition for treating neuropathic pain
|
|
US5919826A
|
|
Method of alleviating pain
|
|
WO9800117A2
|
|
Nonocclusive drug delivery device and process for its manufacture
|
|
US5891885A
|
|
Method for treating migraine
|
|
CA2213842A1
|
|
Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
|
|
US5571079A
|
|
Wound dressing
|
|
US5505958A
|
|
Transdermal drug delivery device and method for its manufacture
|
